Damian J. Green, MD, from Seattle Cancer Care Alliance discusses Identifying Minimum Residual Disease using Flow Cytometry and Next Gen Sequencing in Multiple Myeloma at the 2017 American Society of Hematology.
Advertisement
Identifying Minimum Residual Disease Flow Cytometry, Next Gen Sequencing in Multiple Myeloma
